{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:22Z","timestamp":1786119382093,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003689","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T16:10:21Z","timestamp":1463674221000},"page":"e3689","source":"Crossref","is-referenced-by-count":20,"title":["Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer"],"prefix":"10.1097","volume":"95","author":[{"given":"Mi Joo","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20210226","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3322\/canjclin.47.1.28","article-title":"Tumor-related prognostic factors for breast cancer","volume":"47","author":"Donegan","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"R2-38-20210226","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jso.20061","article-title":"Variability in axillary lymph node dissection for breast cancer","volume":"87","author":"Schaapveld","year":"2004","journal-title":"J Surg Oncol"},{"key":"R3-38-20210226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.10061","article-title":"Early and late morbidity associated with axillary levels I\u2013III dissection in breast cancer","volume":"79","author":"Ernst","year":"2002","journal-title":"J Surg Oncol"},{"key":"R4-38-20210226","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4143\/crt.2010.42.1.30","article-title":"Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size","volume":"42","author":"Lee","year":"2010","journal-title":"Cancer Res Treat"},{"key":"R5-38-20210226","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annonc\/mdm509","article-title":"Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy","volume":"19","author":"Colleoni","year":"2008","journal-title":"Ann Oncol"},{"key":"R6-38-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.coc.0000204405.96572.f9","article-title":"Evaluation of HER-2\/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity","volume":"29","author":"Bozzetti","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"R7-38-20210226","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0959-8049(03)00675-0","article-title":"Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy","volume":"40","author":"Petit","year":"2004","journal-title":"Eur J Cancer"},{"key":"R8-38-20210226","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Carey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R9-38-20210226","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"R10-38-20210226","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjc.1992.230","article-title":"Assessment of morbidity from complete axillary dissection","volume":"66","author":"Ivens","year":"1992","journal-title":"Br J Cancer"},{"key":"R11-38-20210226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.10061","article-title":"Early and late morbidity associated with axillary levels I\u2013III dissection in breast cancer","volume":"79","author":"Ernst","year":"2002","journal-title":"J Surg Oncol"},{"key":"R12-38-20210226","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1002\/j.1460-2075.1987.tb02697.x","article-title":"The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion","volume":"6","author":"Ringwald","year":"1987","journal-title":"Embo J"},{"key":"R13-38-20210226","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-8049(98)00344-X","article-title":"Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling","volume":"35","author":"Ghadimi","year":"1999","journal-title":"Eur J Cancer"},{"key":"R14-38-20210226","first-page":"873","article-title":"A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities","volume":"60","author":"Li","year":"2000","journal-title":"Cancer Res"},{"key":"R15-38-20210226","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/carcin\/bgh223","article-title":"A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer","volume":"25","author":"Shin","year":"2004","journal-title":"Carcinogenesis"},{"key":"R16-38-20210226","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/mc.20765","article-title":"Genetic polymorphism in the 3\u2032-untranslated region of the E-cadherin gene is associated with risk of different cancers","volume":"50","author":"Li","year":"2011","journal-title":"Mol Carcinog"},{"key":"R17-38-20210226","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.7314\/APJCP.2014.15.15.6397","article-title":"Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir","volume":"15","author":"Asiaf","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R18-38-20210226","first-page":"1649","article-title":"Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline","volume":"55","author":"Fan","year":"1995","journal-title":"Cancer Res"},{"key":"R19-38-20210226","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1677\/erc.1.01172","article-title":"Leclercq G. p53 and breast cancer, an update","volume":"13","author":"Lacroix","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"R20-38-20210226","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jnci\/85.3.200","article-title":"Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer","volume":"85","author":"Allred","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R21-38-20210226","first-page":"Fc04","article-title":"Histopathology and prognostic indices of carcinoma breast with special reference to p53 marker","volume":"8","author":"Radha","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"R22-38-20210226","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1128\/MCB.15.10.5770","article-title":"The cellular response to neuregulins is governed by complex interactions of the erbB receptor family","volume":"15","author":"Riese","year":"1995","journal-title":"Mol Cell Biol"},{"key":"R23-38-20210226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"R24-38-20210226","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-008-9914-7","article-title":"Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive","volume":"113","author":"Van Calster","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"R25-38-20210226","first-page":"1","article-title":"HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver","volume":"20","author":"Ledel","year":"2015","journal-title":"Acta Oncol"},{"key":"R26-38-20210226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3857\/roj.2014.32.3.138","article-title":"Outcome of postoperative radiotherapy following radical prostatectomy: a single institutional experience","volume":"32","author":"Lee","year":"2014","journal-title":"Radiat Oncol J"},{"key":"R27-38-20210226","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3857\/roj.2014.32.3.132","article-title":"Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients","volume":"32","author":"Han","year":"2014","journal-title":"Radiat Oncol J"},{"key":"R28-38-20210226","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.2001.19.6.1865","article-title":"2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guideline of the American Society of Clinical Oncology","volume":"15","author":"Bast","year":"2001","journal-title":"J Clin Oncol"},{"key":"R29-38-20210226","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.surg.2006.07.012","article-title":"Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?","volume":"140","author":"Hieken","year":"2006","journal-title":"Surgery"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000003689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:10:14Z","timestamp":1786039814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201605170-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":29,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003689","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}